You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

UNITHROID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Unithroid, and when can generic versions of Unithroid launch?

Unithroid is a drug marketed by Stevens J and is included in one NDA.

The generic ingredient in UNITHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Unithroid

A generic version of UNITHROID was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for UNITHROID?
  • What are the global sales for UNITHROID?
  • What is Average Wholesale Price for UNITHROID?
Drug patent expirations by year for UNITHROID
Drug Prices for UNITHROID

See drug prices for UNITHROID

Drug Sales Revenue Trends for UNITHROID

See drug sales revenues for UNITHROID

Recent Clinical Trials for UNITHROID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)N/A
Children's Hospital of PhiladelphiaN/A
Harvard Medical School (HMS and HSDM)N/A

See all UNITHROID clinical trials

Pharmacology for UNITHROID
Drug Classl-Thyroxine

US Patents and Regulatory Information for UNITHROID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stevens J UNITHROID levothyroxine sodium TABLET;ORAL 021210-001 Aug 21, 2000 AB1,AB2,AB3 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Stevens J UNITHROID levothyroxine sodium TABLET;ORAL 021210-007 Aug 21, 2000 AB1,AB2,AB3 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Stevens J UNITHROID levothyroxine sodium TABLET;ORAL 021210-004 Aug 21, 2000 AB1,AB2,AB3 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.